Specifically, while exogenous GSDMB over-expression into two aggressive murine cancer xenografts models did not affect tumor progression, the treatment with PD-1 immune checkpoint inhibitors activated the GSDMB intrinsic pyroptotic activity in tumor cells through a non-cell autonomous mechanism mediated by NK and CD4+ T cells (Zhou et al., 2020). The gene discussed is CD4; the disease is cancer.